Diacutaneous fibrolysis has documented efficacy in several studies published in impact factor journals. To cite a few examples:
Effects of diacutaneous fibrolysis in patients with mild to moderate symptomatic carpal tunnel syndrome: a randomized controlled trial. Jiménez Del Barrio S1, Estébanez de Miguel E2,3, Bueno Gracia E2,3, Haddad Garay M3, Tricás Moreno JM2,3, Hidalgo García C2,3.
The Effect of Diacutaneous Fibrolysis on Patellar Position Measured Using Ultrasound Scanning in Patients With Patellofemoral Pain Syndrome. Fanlo-Mazas P, Bueno-Gracia E, de Escudero-Zapico AR, Tricás-Moreno JM, Lucha-López MO.
Effectiveness of diacutaneous fibrolysis for the treatment of chronic lateral epicondylalgia: a randomized clinical trial. López-de-Celis C1,2,3, Barra-López ME2,3, González-Rueda V1,3, Bueno-Gracia E4, Rodríguez-Rubio PR2, Tricás-Moreno JM4.
A qualitative analysis of the available publications shows that a variable of fundamental impact on the therapeutic result is the application technique, which must comply with the specific case. Another element to consider is that in some cases diacutaneous fibrolysis can prove painful to become difficult for the patient to endure.
With this in mind, WINTECARE develops a new approach to this therapy: diathermic fibrolysis which adds to the diacutaneous fibrolysis the ability of the fibrolyser to transfer energy to the tissue. This energy translates into a significant and pleasant thermal increase. The most immediate effect on therapy is a considerable reduction in the nociceptive response to treatment, a considerable advantage compared to all categories of patients.
The increase in temperature as well as considerably reducing pain during therapy is also able to stimulate all the “thermal” reactions inherent in energy transfer: above all the possibility of modifying the viscoelasticity of the tissues on which the therapy is concentrated .